Diabetes

An artificial intelligence (AI)-enabled bundled system of sensors and coaching facilitates significant improvements in glycemic outcomes and de-escalation of glucose-lowering pharmacotherapy, according to a study published online Aug. 20 in NEJM Catalyst.

A genetic test of cord blood at birth may hold the key to predicting a child’s future risk of developing type 2 diabetes, according to exciting new research from Australia and Hong Kong.

Researchers from the Global Center for Asian Women’s Health (GloW) and the Department of Obstetrics and Gynecology at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have found that selected maternal biomarkers from first-trimester random blood samples can effectively predict a woman’s risk of gestational diabetes mellitus (GDM).

In a significant research advancement that may help inform treatment strategies for millions of patients worldwide, a research team led by Prof. Fei-Yuan Hsiao of National Taiwan University and Prof. Liang-Kung Chen of National Yang-Ming Chiao Tung University has provided important new insights into a critical clinical question: “Which diabetes medications may offer better lung outcomes for patients with both diabetes and COPD—and does patient frailty matter?”

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review of the technology.

A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of type 2 diabetes mellitus (T2DM) in children and adolescents.

In a first-of-its-kind study, researchers used a unique dataset to show that patients with type 2 diabetes have significantly worse financial outcomes than other patients.

Researchers from Aarhus University—in a major international collaboration—have developed a groundbreaking method that can provide more information from the tissue samples doctors take from patients every day.

Doctors should ask diabetic women at every visit about their intention to have a child, to make sure they get the appropriate care prior to conception, new guidelines say.

Diabetes Mellitus is a chronic metabolic disorder and is one of the leading chronic diseases worldwide. It is widely known for its impact on blood sugar levels and conditions related to the cardiovascular system, kidneys, eyes, and nerves.